Dr. Matthew Edward Herberg, MD

Dr. Herberg practices at The Ear Nose and Throat Surgical Associates PA in Orlando, Florida.

Dr. Herberg's NPI, 1003127556, was assigned on June 30, 2010. Dr. Herberg graduated from New York Medical College in 2010. Dr. Herberg holds Florida license ME160536.

Dr. Herberg's primary practice is The Ear Nose and Throat Surgical Associates PA, at 44 W Michigan St, Orlando, FL 32806 in Orange County. The practice phone is (407) 644-4883.

Dr. Herberg's primary practice is The Ear Nose and Throat Surgical Associates PA in Orlando, Florida. Dr. Herberg is also affiliated with AdventHealth Orlando. The medical group on file is The Ear, Nose, Throat & Plastic Surgery Associates. Dmand AI also links Dr. Herberg to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herberg practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Herberg's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Herberg is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Herberg's licenses on file in 6 states: Florida, Maryland, Texas, New Mexico, District of Columbia and Virginia.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Herberg treats.

CMS data shows 911 Medicare services from Dr. Herberg across 18 procedure codes in 2024, for 440 Medicare patients. Medicare paid $61,131 for them. Every service was in an office.

CMS counts 440 Medicare patients who saw Dr. Herberg in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Herberg's median patient age at 52, with 57% women.

In 2024, Dr. Herberg wrote 267 Medicare Part D claims for 129 patients. 98% of them were for generic drugs. CMS names the drug for 183 of them, across 8 drugs with 11 or more claims each, at $2,515 in total drug cost. In 2023, CMS named 72 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Herberg for performance year 2024, reported as part of a group. Dr. Herberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herberg as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Herberg in 2021. 2021 was the busiest year, with 3. The most frequent topics are Head and Neck Neoplasms, Immunotherapy and Squamous Cell Carcinoma of Head and Neck. Dr. Herberg's most frequent co-authors are Carole Fakhry, MD, David W. Eisele, MD and Rajarsi Mandal, MD.

CMS Open Payments shows 14 general payments to Dr. Herberg from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Inspire Medical Systems, Inc. paid the most, $423.

Dr. Herberg graduated from New York Medical College in 2010. Dr. Herberg is a member of American Board of Otolaryngology - Head and Neck Surgery and ACS.

Dr. Herberg is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.